CIK 0001817241 · <br>Emerging growth company
Artiva Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARTV
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863614316
- Phone
- (858) 267-4467
- Business address
- 5505 MOREHOUSE DRIVE, SAN DIEGO, CA, 92121
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 6,510,416 shares at $11.52 ($74,999,992)
- 8-K Event Other events
- 424B5 Offering Prospectus
- FWP Offering Free Writing Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure · Other events
- 10-K/A Report 10-K/A
- 4 Grant or award Chief Financial Officer acquired 220,000 shares (grant or award)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Shares withheld for taxes SVP, Research and Development gave up 1,521 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Tech Operations Officer gave up 2,187 shares (to pay taxes)
- 4 Shares withheld for taxes COO, CLO, Secy, Compliance Off gave up 3,515 shares (to pay taxes)
Page 5 of 12 · 234 filings